Dr. Yoo Kyung Lee

Yoo Kyung Lee, M.D. Ph.D., is a Gynecologic oncology consultant of Oncology Center.

Major areas of interest are gynecologic cancer surgery including minimally invasive surgery, adjuvant chemotherapy for gynecologic cancer, gynecologic cancer screening including colposcopy.

She has an overall 20 years of professional experience.

After receiving a medical degree from Seoul National University, she had 4 years of residency training in the Department of Obstetrics and Gynecology at Seoul National University Hospital and 3 years of fellowship training in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology at Seoul National University Hospital.

Areas of Interest

Gynecologic cancer surgery including minimally invasive surgery, chemotherapy for gynecologic cancer, gynecologic cancer screening including colposcopy

Education

• MD, Seoul National University, Seoul, Korea
• Ph.D., Seoul National University, Seoul, Korea

Specialty Training

Fellowship

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea

Residency

Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea

Internship

Seoul National University Hospital, Seoul, Korea

Working Experience

• Consultant, Department of Gynecologic Oncology, Sheikh Khalifa Specialty Hospital, RAK, UAE
• Clinical Assistant Professor, Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea
• Assistant Professor, Department of Obstetrics and Gynecology, Cheil General Hospital, Dankook University, Seoul, Korea

Academic Activities

Certificate

• Korean Obstetrics and Gynecology Board certified
• Korean Gynecologic Oncology Board certified

Associations

• Editorial Board: Journal of Gynecologic Oncology
• Committee Secretary: Korean Society of Gynecologic Oncology, Committee of International cooperation
• Committee Chief: Korean Pelvic Pain Society, Committee of Medical Information

Publication

• Kim Y, Seo H, Jeong M, et al. Method to minimize ozone effect on Cy5 fluorescent intensity in DNA microarrays. Analytical biochemistry. 2017; 538: 1-4.
• Lee SW, Lee TS, Hong DG, et al. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. Journal of gynecologic oncology. 2017; 28(1): e12.
• Lee S, Choi S, Lee Y, Chung D, Hong S, Park N. Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer. The journal of obstetrics and gynaecology research. 2017; 43(1): 220-7.
• Lee IH, Kim MK, Lee YK, Hong SR, Lee KH. Primary mucinous adenocarcinoma of the vulva, intestinal type. Obstetrics & gynecology science. 2017; 60(4): 369-73.
• Kim MK, Lee YK, Hong SR, Lim KT. Clinicopathological significance of atypical glandular cells on cervicovaginal Pap smears. Diagnostic cytopathology. 2017.
• Kim HJ, Lee HM, Kim MK, et al. Prognostic assessment of sarcomatous histologic subtypes of ovarian carcinosarcoma. Obstetrics & gynecology science. 2017; 60(4): 350-6.
• Seo HH, Kim YJ, Jeong MS, et al. Combined SYBR Green real-time polymerase chain reaction and microarray method for the simultaneous determination of human papillomavirus loads and genotypes. Obstetrics & gynecology science. 2016; 59(6): 489-97.
• Kim MK, Lee IH, Lee KH, et al. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer. Journal of gynecologic oncology. 2016; 27(2): e14.
• Lee HM, So KA, Kim MK, et al. A case report of a young girl with mucinous borderline tumor of the ovary. Obstetrics & gynecology science. 2016; 59(4): 333-6.
• So KA, Kim MJ, Lee KH, et al. The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study. Cancer research and treatment : official journal of Korean Cancer Association. 2016; 48(4): 1313-20.
• Yu EJ, Park NH, Song YS, Lee YK. Significance of endometrial cells in cervical cytology. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2016: 1-4.
• Yoo SE, So KA, Kim SA, et al. Surgical and obstetrical outcomes after laparoscopic radical trachelectomy and pelvic lymphadenectomy for early cervical cancer. Obstetrics & gynecology science. 2016; 59(5): 373-8.
• Lee YK, Park NH, Lee H. Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancers. Experimental & molecular medicine. 2015; 47: e195.
• Lee YK, Chung HH, Kim JW, Song YS, Park NH. Expression of phosphorylated Akt and hTERT is associated with prognosis of epithelial ovarian carcinoma. International journal of clinical and experimental pathology. 2015; 8(11): 14971-6.
• Koo YJ, Lee JK, Lee YK, et al. Pregnancy Outcomes and Risk Factors for Uterine Rupture After Laparoscopic Myomectomy: A Single-Center Experience and Literature Review. Journal of minimally invasive gynecology. 2015; 22(6): 1022-8.
• Oh S, Kim R, Lee YK, Kim JW, Park NH, Song YS. Clinicopathological aspects of patients with recurrence of borderline ovarian tumors. Obstetrics & gynecology science. 2015; 58(2): 98-105.
• Shin SH, Yu EJ, Lee YK, Song YS, Seong MW, Park SS. Characteristics of hereditary nonpolyposis colorectal cancer patients with double primary cancers in endometrium and colorectum. Obstetrics & gynecology science. 2015; 58(2): 112-6.
• Lee YK, Park I, Lee H. Partial Hepatectomy in Acetylation-Deficient BubR1 Mice Corroborates that Chromosome Missegregation Initiates Tumorigenesis. Endocrinol Metab (Seoul). 2014; 29(4): 561-6.
• Lee YK, Park NH, Lee H. Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2012; 22(3): 434-41.
• Choi E, Park PG, Lee HO, et al. BRCA2 fine-tunes the spindle assembly checkpoint through reinforcement of BubR1 acetylation. Developmental cell. 2012; 22(2): 295-308.
• Lee YK, Chung HH, Kim JW, Park NH, Song YS, Kang SB. Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial. Obstetrics and gynecology. 2011; 117(4): 922-7.
• Lee YK, Park NH. Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers. Gynecologic oncology. 2009; 112(3): 475-80.
• Lee YK, Chung HH, Kang SB. Efficacy and safety of human placenta extract in alleviating climacteric symptoms: prospective, randomized, double-blind, placebo-controlled trial. The journal of obstetrics and gynaecology research. 2009; 35(6): 1096-101.
• Lee YK, Choi E, Kim MA, Park PG, Park NH, Lee H. BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers. British journal of cancer. 2009; 101(3): 504-10.
• Lee YK, Park NH, Kim JW, Song YS, Kang SB, Lee HP. Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecologic oncology. 2008; 108(3): 505-9.
• Lee YK, Park NH, Kim JW, Song YS, Kang SB, Lee HP. Characteristics of recurrence in adult-type granulosa cell tumor. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2008; 18(4): 642-7.
• Han SS, Choi SH, Lee YK, et al. Predictive value of individualized tumor response testing by ATP-based chemotherapy response assay in ovarian cancer. Cancer investigation. 2008; 26(4): 426-30.